cyc 682 has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouvet, M; Hoffman, RM; Katz, MH; Moossa, AR; Spivack, D; Takimoto, S | 2 |
2 other study(ies) available for cyc 682 and Pancreatic Neoplasms
| Article | Year |
|---|---|
Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer.
Topics: Animals; Arabinonucleosides; Cell Division; Cytosine; Humans; Luminescent Proteins; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasm Metastasis; Pancreatic Neoplasms; Red Fluorescent Protein; Transduction, Genetic; Tumor Cells, Cultured; Weight Loss; Xenograft Model Antitumor Assays | 2003 |
Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer.
Topics: Animals; Arabinonucleosides; Cell Line, Tumor; Chemotherapy, Adjuvant; Cytosine; Humans; Male; Mice; Mice, Nude; Pancreatic Neoplasms | 2004 |